Abbott Laboratories NYSE:ABT recently announced financial results for the fourth quarter ended December 31, 2011.
Earnings per share diluted were $1.45, at the high end of company’s previous guidance range, reflecting 11.5 % growth. Under Generally Accepted Accounting Principles (GAAP) the diluted earnings per share were $1.02, including specified items.
The share price of Abbott Laboratories increased 0.27% on Jan 27 EST and closed near $ 55.02. Company’s volume was 6.39 million shares which is above its average volume of 6.93 million shares. Company’s current stock price is moving below its 20 days moving average by 1.00% and it is above its 50 days moving average by 1.00%. Company’s last month price volatility remained 1.00% with beta of 0.3.
Covance Inc. NYSE:CVD, share price increased 0.02% on Jan 27 EST and closed near $43.32. Company’s volume was 2.40 million shares which is below its average volume of 753,646 shares. Company’s current stock price is moving below its 20 days moving average by 6.50% and it is above its 50 days moving average by 6.56%. Company’s last month price volatility remained 2.96% with beta of 1.07.
GlaxoSmithKline plc (ADR) NYSE:GSK, share price decreased 1.28% on Jan 27 EST and closed near $ 44.87. Company’s volume was 2.32 million shares which is above from its average volume of 2.28 million shares. Company’s current stock price is moving below its 20 days moving average by 0.55% and it is below its 50 days moving average by 0.68%. Company’s last month price volatility remained 1.05%.
Infinity Pharmaceuticals Inc. NASDAQ:INFI, share price decreased 39.92% on Jan 27 EST and closed near $ 5.98. Company’s volume was 2.28 million shares which is above from its average volume of 51,867 shares. Company’s current stock price is moving below its 20 days moving average by 34.17% and it is above its 50 days moving average by 33.04%. Company’s last month price volatility remained 6.08%.
